Adaptive CD8 T cell immunity is the principal arm of the cellular alloimmune response, but its development requires help. This can be provided by CD4 T cells that recognise alloantigen 'indirectly', as self-restricted allopeptide, but this process remains unexplained, because the target epitopes for CD4 and CD8 T cell recognition are 'unlinked' on different cells (recipient and donor antigen presenting cells (APCs), respectively). Here, we test the hypothesis that the presentation of intact and processed MHC class I alloantigen by recipient dendritic cells (the 'semi-direct' pathway) allows linked help to be delivered by indirect-pathway CD4 T cells for generating destructive cytotoxic CD8 T cell alloresponses. We show that CD8 T cellmediated rejection of murine heart allografts that lack haematopoietic APCs requires host secondary lymphoid tissue (SLT). SLT is necessary because within it, recipient dendritic cells can acquire MHC from graft parenchymal cells and simultaneously present it as intact protein to alloreactive CD8 T cells and as processed peptide alloantigen for recognition by indirect-pathway CD4 T cells. This enables delivery of essential help for generating cytotoxic CD8 T cell responses that cause rapid allograft rejection. In demonstrating the functional relevance of the semi-direct pathway to transplant rejection, our findings provide a solution to a long-standing conundrum as to why SLT is required for CD8 T cell allorecognition of graft parenchymal cells, and suggest a mechanism by which indirect-pathway CD4 T cells provide help for generating effector cytotoxic CD8 T cell alloresponses at late time points after transplantation.
INTRODUCTION
Cytotoxic CD8 T cell responses directed against MHC Class I alloantigens are one of the principal mediators of acute allograft rejection 1, 2 . Exceptionally, at very high precursor frequency, cytotoxic CD8 T cells can effect graft rejection autonomously 3 and cytotoxic CD8 T cell, but that instead, help is delivered to an intermediary antigen presenting cell (APC), which is then licensed to prime CD8 T cells [4] [5] [6] . A critical requirement for such help is the expression of both the CD4 and CD8 T cell epitopes on the same APC, and an analogous three-cell cluster model ( Figure 1A ) in transplantation is only possible if help for CD8 T cells is provided by CD4 T cells that recognise intact MHC class II alloantigen on the surface of donor APC, via the socalled direct-pathway 7 . Murine studies have confirmed that restricting CD4 T cell help to the direct pathway generates strong cytotoxic CD8 T cell alloresponses that effect rapid allograft rejection 8 .
The indirect-pathway of allorecognition, whereby CD4 T cells recognise processed alloantigen as self-restricted allopeptide 7, 9 , is now viewed as being at least as important as the direct pathway for initiating and mediating allograft rejection. This partly reflects the unique ability of indirect-pathway CD4 T cells to act as helper T cells for generating sophisticated alloantibody responses 10 , but it is now also clear that effective cytotoxic CD8 T cell responses can be generated when CD4 T cell help is restricted exclusively to the indirect-pathway 11 . This is surprising, because the delivery of indirect-pathway T cell help is only readily explained by postulating the unlikely formation of a cumbersome four-cell cluster, comprising CD4 and CD8 T lymphocytes and both recipient and donor APC ( Figure 1b) ; a cluster in which there are no apparent cell surface ligands to enable physical linkage between the donor APC / recipient CD8 T cell couplet and the recipient APC / CD4 T cell couplet. This raises concerns of potentially uncontrolled CD8 T cell alloimmunity, because such 'unlinked' help could in principle be provided by concurrent exposure to any unrelated antigen.
The appreciation that many types of cells, but particularly DCs, can capture ('trogocytose') membrane fragments from other cells 12, 13 has prompted the proposal that cytotoxic CD8 T cell alloimmunity may be initiated by a 'semi-direct' pathway, whereby intact donor MHC class I alloantigen is recognised after its acquisition onto the surface of recipient DCs. In support, murine studies have detailed in vivo capture of membrane alloantigen by host cells 14, 15 . This phenomenon provides a possible mechanism by which the same recipient APC as represents intact MHC class I alloantigen could simultaneously present processed allopeptide for recognition by indirect-pathway CD4 T cells. This would enable formation of a linked three-cell cluster ( Figure 1c ) that obviates many of the concerns associated with the above four-cell cluster model. However, although we have recently demonstrated simultaneous presentation of intact and processed alloantigen by recipient DCs following heart transplantation 16 , the contribution of trogocytosis of alloantigen to graft rejection has yet to be clarified. To have functional relevance, presentation of intact donor alloantigen by recipient APCs must, at least in certain circumstances, be more effective for triggering cytotoxic alloimmunity than conventional encounter on donor APCs, and this has not been shown. Addressing this key concern is challenging, because it requires development of an experimental model in which CD8 T cell allorecognition of target MHC class I alloantigen is limited to the surface of recipient, but not donor, APCs. One way this could perhaps be achieved is by resolving the paradox created by the seminal observations that CD8 T cells can still effect allograft rejection when target MHC class I alloantigen is expressed by graft parenchyma only 17 , but that rejection of vascularised allografts does not occur in the absence of secondary lymphoid tissue 18 . Why secondary lymphoid tissue (SLT) is necessary for CD8 T cell allorecognition of graft parenchymal cells has not been explained, but one elegant and compelling solution is that alloreactive CD8 T cell activation occurs in lymphoid tissue because shed, intact MHC class I alloantigen is only presented by recipient APCs at these sites.
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Here, we show that rejection of heart allografts in mice lacking haematopoietic APCs is mediated by alloreactive CD8 T cells, and that the participation of CD8 T cell is dependent upon the acquisition and presentation of intact MHC Class I alloantigen by recipient DCs within host SLT. We further demonstrate that re-presentation of intact alloantigen enables the delivery of essential help from indirect-pathway CD4 T cells. These findings provide strong functional support for the provision of indirectpathway CD4 T cell help to alloreactive CD8 T cells via a 'linked' three-cell cluster model.
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RESULTS
The requirement for secondary lymphoid tissue for differentiation of effector cytotoxic CD8 T cell alloimmune responses
Key to the proposed 'semi-direct' pathway for generating CD8 T cell alloimmunity is presentation of intact MHC Class I alloantigen by recipient APCs. In the expectation that this presentation would occur chiefly within host SLT, we first sought to determine under what circumstances lymphoid tissue was required for effector CD8
T cell activation and cardiac allograft rejection, by incorporating alymphoplastic (aly/aly) mice that lack lymph nodes and Peyer's patches due to a point mutation in the NF-kB-inducing kinase gene 19 . We also incorporated TCR-transgenic Rag1 -/-2C TCR (2C) mice, whose CD8 T cells recognise H-2L d alloantigen 20 , in the anticipation that when present at high frequency, 2C CD8 T cell activation would not require T cell help, and that this would, for the initial set of experiments, eliminate the confounding role of SLT in initiating helper CD4 T cell responses.
As previously reported T cell alloresponses and for rejection of heart allografts devoid of haematopoietic APCs.
Intact MHC alloantigen is presented by host dendritic cells within SLT
We hypothesised that the requirement for lymphoid tissue to facilitate CD8 T cell mediated rejection of allografts lacking haematopoietic APCs likely reflected a critical role for SLT as the site for presentation of alloantigen (either processed or intact) by recipient DCs. This was examined by creating CD11c-DTR 21 to B6 bone-marrow chimeric recipients (CD11c-DTR-BM), in which it was possible to administer diphtheria toxin at high enough doses to induce profound depletion of recipient DCs.
The CD11c-DTR-BM recipients were reconstituted with an effector 2C CD8 T cell population (not on a DTR background and therefore not susceptible to diphtheria toxin administration), and also received depleting anti-CD4 mAb, to exclude the confounding role for host DCs in activating host CD4 T cells. As expected, CD11c-DTR-BM mice that were reconstituted with 2C CD8 T cells, but that did not receive diphtheria toxin, rejected irradiated BALB/c heart grafts rapidly (MST 13 days; Figure   3a ), with development of moderately strong CD8 T cell alloimmunity (Figure 3b ). In contrast, depletion of the host DCs prolonged allograft survival significantly (MST 26 days, Figure 3a ), albeit heart allografts were still rejected, perhaps indicating that even high doses of diphtheria toxin do not achieve complete or prolonged destruction of the recipient DC population 22, 23 . Graft rejection was dependent upon the transferred 2C CD8 T cell population, because depletion of CD4 T cells prevented, as expected 10 , the generation of alloantibody (not shown) and it is notable that CD4
T cell depleted CD11c-DTR-BM mice that were otherwise unmodified neither rejected irradiated BALB/c heart grafts nor mounted IFN-γ CD8 T cell alloresponses (Figures 3a and 3b ).
This necessity for host DCs to activate CD4 T cell-independent CD8 T cell alloimmunity likely reflects their role in presenting intact MHC class I alloantigen acquired from donor cells. In support, although as previously reported 16 , we were unable to demonstrate acquired MHC class I alloantigen on the surface of host DCs following transplantation (not shown), DCs purified from B6 recipients of an irradiated BALB/c heart graft, provoked an IFN-γ CD8 T cell response upon transfer to secondary naïve B6 mice, albeit this response was weaker than following transfer of DCs purified from recipients of unmodified BALB/c heart allografts (figure 3c). In addition, whereas in vitro culture of purified naïve B6 CD8 T cells with BALB/c endothelial cells generated only minimal CD8 T cell proliferation, the response was The graft rejection kinetics, coupled with the CD8 T cell ELISPOT data, strongly suggest that the cytotoxic CD8 T cell response is mediating graft rejection, but to confirm this, B cell-depleted 'GzmBCrexRosa26YFP' H-2 b mice 24 were challenged with an irradiated BALB/c heart allograft and tamoxifen administered concurrently. 
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DISCUSSION
The present studies address the important question of how CD4 T cell help is provided to alloreactive CD8 T cells for the development of destructive cytotoxic responses, and our results help to resolve a long-standing debate on the mechanism by which help is delivered by CD4 T cells with indirect allospecificity. The use of donor mice deleted of haematopoietic cells, allied to ablation of DCs or absence of host SLT enabled us to confirm that in certain circumstances, host DCs were critical for priming cytotoxic CD8 T cell responses that effected rapid allograft destruction.
In doing so, our findings provide a solution to the paradox created by two earlier landmark studies that observed that SLT was required for rejection of a vascularised allograft 18 , but that cytotoxic CD8 T cells could mediate allograft rejection when expression of target MHC class I alloantigen was limited to graft parenchyma 17 .
Moreover, because our model was refined to exclude the contribution of alternative effector mechanisms of graft rejection, we believe our manuscript is the first to demonstrate the functional relevance of the 'semi-direct' pathway to transplant It is striking that host SLT is required for 2C CD8 T cell mediated rejection of irradiated heart allografts, but not for rejection of wild-type heart grafts with an intact haematopoietic component. This presumably relates to differences in the availability of target MHC class I alloantigen; that even in the absence of SLT, the 
Heterotopic cardiac transplantation
Vascularised cardiac allografts were transplanted intra-abdominally using the technique of Corry and colleagues 37 . Splenectomy was performed in aly/aly recipient mice prior to implantation of the donor organ. In experiments involving GzmBCrexRosa26YFP mice as recipients or transfer of purified GzmBCrexRosa26YFP CD8 T cells, 1mg tamoxifen was administered i.p. to the recipient the day before and every second day after transplant. Graft rejection was defined as cessation of palpable myocardial contraction, confirmed at explant.
Purification and adoptive transfer of leucocyte subsets
2C transgenic CD8 T cells were purified from Rag1 -/-2C TCR mice using an autoMACS Separator (Mitenyi Biotec). 'Activated' 2C TCR CD8 were obtained by purification Dendritic cells were purified from recipient mice spleens four days after transplantation with a heart graft and adoptively transferred into naïve secondary C57Bl/6 mice as described previously 16 . Naïve secondary mice received 3 x 10 6 cells (the approximate total recovered from four recipients) transferred i.v.
Generation of bone marrow chimeras
Chimeric mice that were CD11c-DTR + only in the haematopoietic compartment (CD11c-DTR-BM mice) were created by lethally-irradiating C57BL/6 mice (13 Gy in 2 x 6.5 Gy fractions) and reconstituting with 2 x 10 7 bone marrow cells from C57BL/6.CD11c-DTR mice. Such chimeric mice tolerate high doses of diphtheria toxin necessary to induce profound depletion of the DC fraction without developing the severe toxicity associated with those doses in standard CD11c-DTR mice 38 .
Chimerism was confirmed by flow cytometric analysis of PBMCs 4 weeks following reconstitution.
Dendritic cell, T and B cell depletion.
CD11c-DTR-BM chimeric heart graft recipients were treated with i. Because of concerns that CD8 T cells are resistant to treatment with depleting anti CD8 mAb 11 , combined B and CD8 T cell depletion was instead achieved by reconstituting Rag2 -/-C57BL/6 mice with C57Bl/6 CD4 T cells, purified using standard magnetic bead separation (Mitenyi Biotec).
Depletion of the haematopoietic cell fraction in donor mice.
Depletion of haematopoietic cells in donor BALB/c mice was achieved by lethal irradiation (13 Gy in 2 x 6.5 Gy fractions) on day -7 and treatment with 1 mg i.p. pathway') does not provoke a response 10 .
CFSE CD4 T cell proliferation and Flow cytometry
Proliferation of TCR75 CD4 T cells was determined by CFSE-labelled cell division at day 7 following adoptive transfer, as described previously 10 . FITC conjugated CD11c 
Assay of circulating anti-H-2K d alloantibody and CD8 T cell ELISPOT.
Serum samples were collected from experimental mice at intervals and analysed for the presence of anti-H-2Kd IgG alloantibody by ELISA as previously described 10 . For each sample, an absorbance vs. dilution curve was plotted, and the area under the curve calculated 39 and expressed as the percentage of positive control (pooled hyperimmune) serum. CD8 T cell ELISPOT was performed as described 40 .
Statistical analysis
Data were presented as mean ± SEM where appropriate. Mann-Whitney-U test was used for analysis of nonparametric data. Graft survival was depicted using KaplanMeier analysis and groups compared by log-rank (Mantel-Cox) testing. Analysis was conducted using GraphPad 4 (Graph-Pad Software, San Diego, CA, USA). Values of P < 0.05 were considered significant.
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Mice were bred and maintained in specific-pathogen-free animal facilities and all experiments were approved by the United Kingdom Home Office under the Animal (Scientific Procedures) Act 1986. All mice were 6-10 weeks of age at the beginning of the experiments.
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